Previous studies have demonstrated that some 30% of COVID-19 in-patients receive antibiotics for community-acquired pneumonia, whilst only about 5% of them had confirmed bacterial infections. Pulia and colleagues sought to assess whether there was a clinical benefit for these patients versus concerns of antibiotic stewardship and individual patient harms.

Read the article here.